Nordhealth AS (OSL:NORDH)
27.20
0.00 (0.00%)
At close: Mar 13, 2026
Nordhealth AS Revenue
In the year 2025, Nordhealth AS had annual revenue of 50.84M EUR with 11.31% growth. Nordhealth AS had revenue of 12.57M in the quarter ending December 31, 2025, with 3.86% growth.
Revenue
50.84M EUR
Revenue Growth
+11.31%
P/S Ratio
3.62
Revenue / Employee
109.57K EUR
Employees
464
Market Cap
2.18B NOK
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 50.84M | 5.17M | 11.31% |
| Dec 31, 2024 | 45.68M | 8.85M | 24.03% |
| Dec 31, 2023 | 36.83M | 5.78M | 18.60% |
| Dec 31, 2022 | 31.05M | 10.75M | 52.96% |
| Dec 31, 2021 | 20.30M | 7.62M | 60.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medistim ASA | 699.77M |
| Navamedic ASA | 565.36M |
| Photocure ASA | 532.58M |
| Omda AS | 495.69M |
| Vistin Pharma ASA | 452.29M |
| Gentian Diagnostics ASA | 176.50M |
| ArcticZymes Technologies ASA | 118.21M |
| Nykode Therapeutics AS | 4.57M |
Nordhealth AS News
- 3 days ago - Nordhealth AS (STU:6E5) Q4 2025 Earnings Call Highlights: Revenue Growth and Strategic AI ... - GuruFocus
- 3 days ago - Q4 2025 Nordhealth AS Earnings Call Transcript - GuruFocus
- 4 months ago - Nordhealth AS (FRA:6E5) Q3 2025 Earnings Call Highlights: Revenue Growth and AI Investments ... - GuruFocus
- 4 months ago - Q3 2025 Nordhealth AS Earnings Call Transcript - GuruFocus